Strs Ohio decreased its stake in Henry Schein Inc. (NASDAQ:HSIC) by 32.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,721 shares of the company’s stock after selling 3,765 shares during the period. Strs Ohio’s holdings in Henry Schein were worth $1,365,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wagner Bowman Management Corp purchased a new position in Henry Schein during the second quarter valued at $231,000. Berkshire Asset Management LLC PA bought a new stake in shares of Henry Schein during the second quarter valued at approximately $246,000. Eqis Capital Management Inc. increased its stake in shares of Henry Schein by 23.4% in the second quarter. Eqis Capital Management Inc. now owns 1,639 shares of the company’s stock valued at $290,000 after buying an additional 311 shares during the period. Copper Rock Capital Partners LLC bought a new stake in shares of Henry Schein during the second quarter valued at approximately $354,000. Finally, Magnetar Financial LLC bought a new stake in shares of Henry Schein during the first quarter valued at approximately $424,000. 91.98% of the stock is currently owned by institutional investors and hedge funds.
Shares of Henry Schein Inc. (NASDAQ:HSIC) traded down 2.70% during trading on Tuesday, reaching $158.63. 983,393 shares of the company were exchanged. The firm’s 50 day moving average price is $162.66 and its 200 day moving average price is $170.44. Henry Schein Inc. has a one year low of $140.11 and a one year high of $183.00. The company has a market capitalization of $12.98 billion, a PE ratio of 26.87 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.63 by $0.01. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The company’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.46 EPS. Equities research analysts forecast that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.
HSIC has been the topic of several research analyst reports. Goldman Sachs Group Inc. upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating in a report on Tuesday. Bank of America Corp. initiated coverage on shares of Henry Schein in a report on Monday, September 12th. They set a “buy” rating and a $185.00 target price on the stock. Zacks Investment Research upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Monday, September 12th. Finally, Robert W. Baird restated an “outperform” rating and set a $176.00 target price (up from $175.00) on shares of Henry Schein in a report on Tuesday, October 4th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Henry Schein currently has an average rating of “Buy” and an average target price of $157.92.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now directly owns 13,715 shares in the company, valued at approximately $2,249,671.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.